Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience
Title:
Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience
Author:
Papayannidis, Cristina Paolini, Stefania Santoro, Alessandra Robustelli, Valentina Soverini, Simona De Benedittis, Caterina Imbrogno, Enrica Terragna, Carolina Luserna di Rora, Andrea Ghelli Parisi, Sarah Sartor, Chiara Marconi, Giovanni Lomonaco, Silvia Abbenante, Maria Chiara Martinelli, Giovanni